Detection method, probe set, and diagnostic kit for predicting postoperation recurrence-free survival of colorectal cancer via gene expression states of two probes

A diagnostic kit and gene expression technology, applied in the direction of recombinant DNA technology, DNA / RNA fragments, etc., can solve the problems of lack of specific clinical manifestations, difficulties, recurrence and metastasis, and achieve the effect of improving survival rate and prolonging survival time

Inactive Publication Date: 2015-02-25
CHINESE NAT HUMAN GENOME CENT AT SHANGHAI +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the lack of obvious early symptoms of colorectal cancer, the lack of specific clinical manifestations, and the poor self-care awareness of patients or the avoidance of medical treatment, early detection and diagnosis of colorectal cancer are relatively difficult. Clinically, more than 60-70% Most of the patients were diagnosed with advanced colorectal cancer, and among the stage II and stage III patients who can undergo radical surgery for colorectal cancer, about 20% and 50% of the patients will relapse and metastasize after operation, depending on the condition Adjuvant therapy such as chemotherapy or radiotherapy
However, tumor recurrence and metastasis involve many gene changes, and the process is quite complicated. Therefore, it is difficult to predict the risk of postoperative recurrence and metastasis of patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection method, probe set, and diagnostic kit for predicting postoperation recurrence-free survival of colorectal cancer via gene expression states of two probes
  • Detection method, probe set, and diagnostic kit for predicting postoperation recurrence-free survival of colorectal cancer via gene expression states of two probes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0017] The following examples are only used to illustrate the present invention, but not to limit the scope of the present invention. The experimental methods without specific conditions in the examples usually follow the conventional conditions, such as the conditions described in Sambrook et al., Molecular Cloning: Laboratory Manual (New York: Cold Spring Harbor Laboratory Press, 1989), or according to the manufacturer The suggested conditions.

[0018] 1. Subject

[0019] The subject of this example was selected from June to December 2004, in the Department of Colorectal Surgery, Fudan University Affiliated Tumor Hospital, 172 patients with stage II-III colorectal cancer who underwent radical surgery and had no distant metastasis in the preoperative examination . After all the above-mentioned patients have completed postoperative adjuvant treatment and entered the simple follow-up period, a second screening was carried out, and 29 patients with stage II who did not receive adj...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention discloses a detection method for predicting postoperation recurrence-free survival of colorectal cancers via gene expression states of two probes. The method includes: collecting cancerous tissue specimens excised in an operation of a colorectal cancer patient, extracting RNA samples, purifying the RNA samples, detecting the expressions of two specific probes, and calculating the number of a high expression probe to evaluate the patient's prognosis. The invention also discloses a probe set composed by the two probes, and a diagnostic kit containing the probe set. The detection method of the invention helps to improve the survival rate of the colorectal cancer patients. The risk degree of postoperative recurrence and metastasis occurrence of the patients can be quickly determined through the detection and the joint analysis of the two specific probes after that the colorectal cancer patients receive radical operations, so the detection method enables adjuvant treatments for the patients with a higher risk degree of recurrence to be done early to help prolong the survival time of the patients.

Description

Technical field [0001] The present invention relates to the prognosis field of colorectal cancer, in particular to a detection method for predicting recurrence-free survival after colorectal cancer operation based on the expression of two genes. The invention also relates to a probe set and a diagnostic kit used in the method. Background technique [0002] Colorectal cancer generally refers to malignant tumors that occur in the rectum and all colons (ascending colon, transverse colon, descending colon, sigmoid colon), and is one of the common malignant tumors in clinical practice. At present, there are about 800,000 new cases of colorectal cancer in China each year, and 500,000 people die from colorectal cancer each year. Due to changes in living conditions and habits, the incidence of colorectal cancer is still increasing year by year. Compared with the 1990s and 1970s, the incidence of colorectal cancer has increased by 31.95% in cities and 8.51 in rural areas. %. Among the f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/68C12N15/11
Inventor 黄薇蔡三军王志敏彭俊杰王海丰徐烨牛振民
Owner CHINESE NAT HUMAN GENOME CENT AT SHANGHAI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products